White Paper

An Innovative Approach To Manufacturing Custom CDM With Precision Accuracy

Source: Cytiva

By Christopher J. Woolstenhulme, Nathan D. Israelsen, Damien Bellos, Alexandre Pereiras MagariƱos, and Andra Kunzler

Cytiva image (002)

Chemically defined cell culture media have been widely adopted in biomanufacturing processes to produce biotherapeutics such as biosimilars, vaccines, and monoclonal antibodies. Performance of these biotherapeutics can be greatly affected by trace impurities introduced by the media raw materials. The additive effect of trace impurities can dramatically increase concentrations of components, including metal salts and other trace impurities. Therefore, precise control of trace impurities is crucial for drug consistency and performance.

Here, a novel approach for manufacturing chemically defined media with precision control of trace impurities is presented. This approach utilizes a combination of innovative raw material analysis, data analytics, and a proprietary algorithm to select raw material lots to manufacture media containing metal and other trace impurity concentrations within customer-defined limits.

access the White Paper!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Biosimilar Development